Implantation of plateletpheresis in the hemotherapy service of a reference university hospital in Alagoas, Brazil

Authors

DOI:

https://doi.org/10.33448/rsd-v11i11.33564

Keywords:

Blood Bank; Blood Donors; Blood Platelets; Blood component removal.

Abstract

Introduction: Apheresis is a procedure where blood from a single donor is withdrawn, separated into red blood cells, plasma and platelets. Plateletpheresis is important in the transfusion therapy of cancer patients, reducing the chances of transfusion-related diseases and transfusion reactions. Objective: To present a comparative analysis of the apheresis collection procedures of a hemotherapy service between the years 2017 and 2018, the initial period of its implementation. Methods: 162 apheresis protocols from the blood collection sector of the Transfusion Unit of the University Hospital were used in this study. This is a retrospective, observational study, with a review of data from apheresis donation procedures. Results: 62 apheresis procedures were performed, totaling 200 blood components during the research period. The highest incidence of donors was male (93%) compared to female (7%). We identified 49 cases of adverse reactions to donation (30.2%), the most frequent being: hematoma at the puncture site (40.81%) and lip tingling (38.78%), followed by vasovagal reaction ( 16.33%). Conclusion: The implementation of platelet collection by apheresis in the hemotherapy service promoted greater support for the care of patients with high transfusion needs, agility and improvement in the quality of the blood component offered.

References

Anderson, C. (2010). Selection and care of apheresis donors. In: Mcleod, B. C., Szczepiorkowski, Z. M., Weinstein, R., Winters, J. L. editors. Apheresis: Principles and Practice (3rd ed.,) Ch. 5. Bethesda, Maryland: AABB Press. 2010. p. 111-122.

Barbosa, M. H., Silva, K. F. N., Coelho, D. Q., Tavares, J. L., Cruz, L. F., & Kanda, M. H. (2014). Risk factors associated with the occurrence of adverse events in plateletpheresis donation. Revista Brasileira de Hematologia e Hemoterapia, 36(3), 191-195. https://doi.org/10.1016/j.bjhh.2014.03.008

Bassi, R., Thakur, K, K., & Bhardwaj, K. (2017). Plateletpheresis adverse events in relation to donor and plateletpheresis session profile. Iraqi Journal of Hematology, 6(2), 38-42. http://dx.doi.org/10.4103/ijh.ijh_14_17

Brasil. (2014). Guia para o uso de Hemocomponentes. Brasília: Editora Saúde, 2014.

Chopra, S., Kaur, P., Bedi, R. K., & Kaur, G. (2021). Effect of double dose plateletpheresis on target yield and donor platelet recovery. Hematology Transfusion and Cell Therapy, S2531-1379. http://www.htct.com.br/en-effect-double-dose-plateletpheresis-on-avance-S2531137921000833

Crookston, K. P., &Novak, D. J. (2010). Physiology of apheresis. In: Mcleod, B. C., Szczepiorkowski, Z. M., Weinstein, R., Winters, J. L. editors. Apheresis: Principles and Practice (3rd ed.,) Ch. 3. Bethesda, Maryland: AABB Press. 2010. p. 45-65.

Fundação Hemominas. (2012). Manual de Normas e Procedimentos de Atendimento ao Doador.

Jang, C. S., Kim, S. I., Kim, H. K., Kweon, C. O., Kim, B. W., Kim, D. C., Kim, Y. S., Rhee, K. J., & Ryu, J. K. (2014). Plateletpheresis: the Process, Devices, and Indicators of Product Quality. Journal of Life Science, 24(9), 1030-1038. https://doi.org/10.5352/JLS.2014.24.9.1030

Holinstat, M. (2017). Normal platelet function. Cancer Metastasis Rev, 36(2), 195-198. https://doi.org/10.1007%2Fs10555-017-9677-x

Katz, L., Palmer, K., McDonnell, E., & Kabat, A. (2007). Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors. Transfusion, 2007; 47(9), 1601-1606. https://doi.org/10.1111/j.1537-2995.2007.01330.x

Lazarus, E. F., Browning, J., Norman, J., Oblitas, J., & Leitman, S.F. (2001). Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations. Transfusion. 41(6), 756-761. https://doi.org/10.1046/j.1537-2995.2001.41060756.x

Legler, T. J., Fischer, I., Dittmann, J., Simson, G., Lynen, R., Humpe, A., Riggert, J., Schleyer, E., Kern, W., Hiddemann, W., & Kohler, M. (1997). Frequency and causes of refractoriness in multiply transfused patients. Annals of Hematology, 74(4), 185-189. https://doi.org/10.1007/s002770050280

Loureiro, L. P. L. A., Zielak, S. L., Almeida, I. L. H. G., Barbosa, K. L., & Araújo, C. P. L. C. (2021). Profile of apheresis donors at Professor Alberto Antunes University Hospital of the Federal University of Alagoas. Medicina (Ribeirão Preto), 54(2), e-167273. https://doi.org/10.11606/issn.2176-7262.rmrp.2021.168490

Nayak, S., Coshi, P., Pandey, R. M., & Chatterjee, K. (2019). Frequent plateletpheresis donations & its effect on haematological parameters: An observational study. The Indian Journal of Medical Research, 150(5), 468-476. https://doi.org/10.4103%2Fijmr.IJMR_512_18

Rodrigues, R. S. M., & Reibnitz, K. S. (2011). Estratégias de captação de doadores de sangue: uma revisão integrativa da literatura. Texto & Contexto Enfermagem, 20(2), 384-391. https://doi.org/10.1590/S0104-07072011000200022

Santos, R. B., Gomes, C. M., Bonadio, C. B., Ferreira, P. de S., Bertequini, R. B., Rodrigues, L. F. (2019). Retrospective Observational Study about Patient’s Profile who Reveived Palliative Sedation Therapy at the Palliative Care Unit in a Brazilian Cancer Hospital. Revista Brasileira de Cancerologia, 65(1), e-09324. https://doi.org/10.32635/2176-9745.RBC.2019v65n1.324

Schiffer, C. A., Anderson, K. C., Bennett, C. L., Bernstein, S., Elting, L. S., Goldsmith, M., Goldsmith, M., Hume, H., McCullough, J. J., McIntyre, R. W., et al. (2001). Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology, 19(5), 1519-1538. https://doi.org/10.1200/jco.2017.76.1734

Slichter, S. J., Davis, K., Enright, H., Braine, H., Gernsheimer, T., Kao, K. J., Kickler, T., Lee, E., McFarland, J., McCullough, J., et al. (2005). Factors affecting post-transfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood, 105(10), 4106-4114. https://doi.org/10.1182/blood-2003-08-2724

U.S. Department of Health and Human Services. (2007). Guidance for Industry and FDA Review Staff: collection of Platelets by Automated Methods. Rockville (MD): U.S. Food and Drug Administration, Center for Biologics Evaluation and Research.

Winters, J. L. (2006). Complications of donor apheresis. Journal of Clinical Apheresis, 21(2), 132-141. https://doi.org/10.1002/jca.20039

Published

19/08/2022

How to Cite

BARBOSA, K. L. .; PEREIRA, K. R. L. .; GALVÃO, I. L. de H. .; LEITE, D. B. .; LESSA, E. E. A. .; CHAGAS, K. P. A. .; SOARES, M. A. .; ARAÚJO, C. P. L. C. de .; BRÊDA, D. M. de L. .; PEREIRA, L. de A. . Implantation of plateletpheresis in the hemotherapy service of a reference university hospital in Alagoas, Brazil. Research, Society and Development, [S. l.], v. 11, n. 11, p. e160111133564, 2022. DOI: 10.33448/rsd-v11i11.33564. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/33564. Acesso em: 28 sep. 2022.

Issue

Section

Health Sciences